Antagonists or neutralizing antibodies against IL-1, TNF-, and IL-6, such as IL-1Ra and anti-TNF-, have been extensively studied in OA
Risks of Buying GLP-1 Internationally Safety and efficacy are the two biggest concerns when sourcing medication across borders
The translation of these promising preclinical findings into viable clinical applications faces considerable challenges
Licensed in the UK for type 2 diabetes mellitus and chronic weight management in adults with obesity or overweight with comorbidities
Complete Your Medical Evaluation Discuss your health history, medications, symptoms, sleep, recovery, body composition goals, and overall wellness objectives
Conclusions This study analyzed public Facebook posts to examine public discussion of adverse events associated with GLP-1 RAs from 2022 to 2024